User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Conservative bladder management in advanced multiple sclerosis

Primary tabs

De Ridder, Dirk [UCL] Ost, D Van der Aa, F Stagnaro, M Beneton, C Nordenbo, A.

Anticholinergics and intermittent catheterization are the cornerstones of bladder management in early multiple sclerosis (MS). In advanced MS however, bladder management is based more on tradition than on evidence. Nurses seem to deal with catheter problems and chronic incontinence. Despite the abundant use of indwelling catheters, there is a lack for guidelines on catheter-induced problems. The psychosexual and social impact of bladder problems in advanced MS is often neglected. The international multidisciplinary special interest group on sexual, urological and bowel dysfunction in MS (SUBDIMS) as a special interest group of the Rehabilitation in Multiple Sclerosis (RIMS) was confronted with a high variability in practice and a lack of guidelines. A literature review was prepared during three multidisciplinary expert meetings. This review will be the basis of further initiatives to improve the urological treatment of patients with advanced MS.

Document type Article de périodique (Journal article) – Article de recherche
Publication date 2005
Language Anglais
Journal information "Multiple Sclerosis : clinical and laboratory research" - Vol. 11, no. 6, p. 694-699 (2005)
Peer reviewed yes
Publisher Hodder Arnold, Hodder Headline Plc (London)
issn 1352-4585
e-issn 1477-0970
Publication status Publié
Affiliation UCL
Keywords multiple sclerosis ; neurogenic bladder ; overactive bladder ; urinary catheter
Links
  1. Fowler C J, van Kerrebroeck P E, Nordenbo A, Van Poppel H, Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. Committee of the European Study Group of SUDIMS (Sexual and Urological Disorders in Multiple Sclerosis), 10.1136/jnnp.55.11.986
  2. LITWILLER SCOTT E., FROHMAN ELLIOT M., ZIMMERN PHILIPPE E., MULTIPLE SCLEROSIS AND THE UROLOGIST, 10.1016/s0022-5347(01)61760-9
  3. Lawrenson Ross, Wyndaele Jean-Jacques, Vlachonikolis Ioannis, Farmer Christopher, Glickman Scott, Renal Failure in Patients with Neurogenic Lower Urinary Tract Dysfunction, 10.1159/000054774
  4. Hillman Leslie J, Burns Stephen P, Kraft George H, Neurological worsening due to infection from renal stones in a multiple sclerosis patient, 10.1177/135245850000600608
  5. Amarenco G, Presse Med, 25, 1007 (1996)
  6. Kasabian Nabet G., Krause Ira, Brown Wendy E., Khan Zafar, Nagler Harris M., Fate of the upper urinary tract in multiple sclerosis, 10.1002/nau.1930140113
  7. Giannantoni Antonella, Scivoletto Giorgio, Di Stasi Savino M., Grasso Maria Grazia, Vespasiani Giuseppe, Castellano Vincenzo, Urological dysfunctions and upper urinary tract involvement in multiple sclerosis patients, 10.1002/(sici)1520-6777(1998)17:2<89::aid-nau2>3.0.co;2-8
  8. Wan Julian, Fleenor Sharon, Kielczewski Patricia, McGuire Edward J., Urinary Tract Status of Patients with Neurogenic Dysfunction Presenting with Upper Tract Stone Disease, 10.1016/s0022-5347(17)36838-6
  9. Jamil, Williamson, Ahmed, Harrison, Natural-fill urodynamics in chronically catheterized patients with spinal-cord injury : INDWELLING CATHETER FOR NEUROPATHIC BLADDER, 10.1046/j.1464-410x.1999.00933.x
  10. Gerridzen Ronald G., Thijssen Anthony M., Dehoux Eric, Risk Factors for Upper Tract Deterioration in Chronic Spinal Cord Injury Patients, 10.1016/s0022-5347(17)37254-3
  11. De Ridder D, Van Poppel H, Baert L, Binard J, From time dependent intermittent selfcatheterisation to volume dependent selfcatheterisation in Multiple Sclerosis using the PCI 5000 Bladdermanager, 10.1038/sj.sc.3100446
  12. Timoney A G, Shaw P J R, Urological outcome in female patients with spinal cord injury: the effectiveness of intermittent catheterisation, 10.1038/sc.1990.75
  13. De Ridder Dirk, Chandiramani Vijay, Dasgupta Prokar, Van Popple H., Baert Luc, Fowler Clare J., INTRAVESICAL CAPSAICIN AS A TREATMENT FOR REFRACTORY DETRUSOR HYPERREFLEXIA: A DUAL CENTER STUDY WITH LONG-TERM FOLLOWUP, 10.1016/s0022-5347(01)68162-x
  14. De Ridder D., Baert L., Vanilloids and the overactive bladder : VANILLOIDS, 10.1046/j.1464-410x.2000.00750.x
  15. SCHURCH B., STÖHRER M., KRAMER G., SCHMID D.M., GAUL G., HAURI D., BOTULINUM-A TOXIN FOR TREATING DETRUSOR HYPERREFLEXIA IN SPINAL CORD INJURED PATIENTS: A NEW ALTERNATIVE TO ANTICHOLINERGIC DRUGS? PRELIMINARY RESULTS, 10.1016/s0022-5347(05)67283-7
  16. Schurch B., Hauri D., Rodic B., Curt A., Meyer M., Rossier Alain B., Botulinum-A Toxin as a Treatment of Detruosor-Sphincter Dyssynergia: A Prospective Study in 24 Spinal Cord Injury Patients, 10.1016/s0022-5347(01)66376-6
  17. PHELAN MICHAEL W., FRANKS MICHAEL, SOMOGYI GEORGE T., YOKOYAMA TERUHIKO, FRASER MATTHEW O., LAVELLE JOHN P., YOSHIMURA NAOKI, CHANCELLOR MICHAEL B., BOTULINUM TOXIN URETHRAL SPHINCTER INJECTION TO RESTORE BLADDER EMPTYING IN MEN AND WOMEN WITH VOIDING DYSFUNCTION, 10.1016/s0022-5347(05)66438-5
  18. PHELAN MICHAEL W., FRANKS MICHAEL, SOMOGYI GEORGE T., YOKOYAMA TERUHIKO, FRASER MATTHEW O., LAVELLE JOHN P., YOSHIMURA NAOKI, CHANCELLOR MICHAEL B., BOTULINUM TOXIN URETHRAL SPHINCTER INJECTION TO RESTORE BLADDER EMPTYING IN MEN AND WOMEN WITH VOIDING DYSFUNCTION, 10.1016/s0022-5347(05)66438-5
  19. Somerset Maggie, Campbell Rona, Sharp Deborah J., Peters Tim J., What do people with MS want and expect from health-care services?, 10.1046/j.1369-6513.2001.00111.x
  20. Carriot F, Rev D Epidemiol San Publ, 48, 473 (2000)
  21. MARSELOS MARIOS, KARAMANAKOS PETROS, Mutagenicity, developmental toxicity and carcinogenicity of cannabis, 10.1080/13556219971786
  22. Zajicek John, Fox Patrick, Sanders Hilary, Wright David, Vickery Jane, Nunn Andrew, Thompson Alan, Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial, 10.1016/s0140-6736(03)14738-1
  23. Duran Marta, Laporte Joan-Ramon, Capellà Dolors, Novedades sobre las potencialidades terapéuticas del Cannabis y el sistema cannabinoide, 10.1016/s0025-7753(04)74251-7
  24. O’Leary Margie, Erickson Janet R., Smith Christopher P., McDermott Charlotte, Horton John, Chancellor Michael B., Effect Of Controlled-Release Oxybutynin On Neurogenic Bladder Function In Spinal Cord Injury, 10.1080/10790268.2003.11753678
  25. Amarenco G, Prog Urol, 2, 660 (1992)
  26. Ferreira Ema, Letwin Shallen R, Desmopressin for Nocturia and Enuresis Associated with Multiple Sclerosis, 10.1345/aph.17158
  27. Valiquette Guy, Desmopressin in the Management of Nocturia in Patients With Multiple Sclerosis : A Double-blind, Crossover Trial, 10.1001/archneur.1996.00550120082020
  28. Odeh Majed, Oliven Arie, Coma and Seizures due to Severe Hyponatremia and Water Intoxication in an Adult with Intranasal Desmopressin Therapy for Nocturnal Enuresis, 10.1177/00912700122010320
  29. Miller Myron, Nocturnal Polyuria in Older People: Pathophysiology and Clinical Implications, 10.1111/j.1532-5415.2000.tb02608.x
  30. Tomasi P.A., Siracusano S., Monni A.M., Mela G., Delitala G., Decreased nocturnal urinary antidiuretic hormone excretion in enuresis is increased by imipramine : ENURESIS AND ADH, 10.1046/j.1464-4096.2001.02434.x
  31. Koch Tina, Kralik Debbie, Eastwood Sue, Schofield Ann, Breaking the silence: Women living with multiple sclerosis and urinary incontinence, 10.1046/j.1440-172x.2001.00241.x
  32. Koch T, Aust J Holist Nurs, 6, 14 (1999)
  33. Knight Robert G., Devereux Robert C., Godfrey Hamish P. D., Psychosocial consequences of caring for a spouse with multiple sclerosis, 10.1080/01688639708403832
  34. Sheriff M K M, Foley S, McFarlane J, Nauth-Misir R, Craggs M, Shah P J R, Long-term suprapubic catheterisation: clinical outcome and satisfaction survey, 10.1038/sj.sc.3100536
  35. Chao Roberto, Clowers Diane, Mayo Michael E., Fate of upper urinary tracts in patients with indwelling catheters after spinal cord injury, 10.1016/0090-4295(93)90613-f
  36. Chao Roberto, Mayo Michael E., Bejany Darwiche E., Bavendam Tamara, Bladder Neck Closure with Continent Augmentation or Suprapubic Catheter in Patients with Neurogenic Bladders, 10.1080/01952307.1993.11735879
  37. Morris N.S., Stickler D.J., Encrustation of indwelling urethral catheters by Proteus mirabilis biofilms growing in human urine, 10.1016/s0195-6701(98)90262-6
  38. Kohler-Ockmore J., Feneley R.C.L., Long-term catheterization of the bladder:, 10.1046/j.1464-410x.1996.09074.x
  39. Burr R G, Nuseibeh I M, Urinary catheter blockage depends on urine pH, calcium and rate of flow, 10.1038/sj.sc.3100424
  40. Burr R G, Chem C, Nuseibeh I, Creatinine, calcium, citrate and acid-base in spinal cord injured patients, 10.1038/sc.1993.116
  41. Tambyah PA, Arch Intern Med, 160, 678 (2000)
  42. Ho Chester H., Kirshblum Steven, Linsenmeyer Todd A., Millis Scott R., Effects of The Routine Change of Chronic Indwelling Foley Catheters In Persons with Spinal Cord Injury, 10.1080/10790268.2001.11753563
  43. Polastri François, Auckenthaler Raymond, Loew François, Michel Jean-Pierre, Lew Daniel P., Absence of Significant Bacteremia During Urinary Catheter Manipulation in Patients With Chronic Indwelling Catheters, 10.1111/j.1532-5415.1990.tb01500.x
  44. RAZ RAUL, SCHILLER DAVID, NICOLLE LINDSAY E., CHRONIC INDWELLING CATHETER REPLACEMENT BEFORE ANTIMICROBIAL THERAPY FOR SYMPTOMATIC URINARY TRACT INFECTION, 10.1016/s0022-5347(05)67150-9
  45. Warren John W., Catheter-Associated Bacteriuria in Long-Term Care Facilities, 10.2307/30148409
  46. Warren John W., Catheter-associated urinary tract infections, 10.1016/s0924-8579(00)00359-9
  47. Reid G, Hsiehl J, Potter P, Mighton J, Lam D, Warren D, Stephenson J, Cranberry juice consumption may reduce biofilms on uroepithelial cells: pilot study in spinal cord injured patients, 10.1038/sj.sc.3101099
  48. Schlager Theresa A., Anderson Susan, Trudell Julie, Hendley Joseph O., Effect of cranberry juice on bacteriuria in children with neurogenic bladder receiving intermittent catheterization, 10.1016/s0022-3476(99)70087-9
  49. Morris N.S., Stickler D.J., Does drinking cranberry juice produce urine inhibitory to the development of crystalline, catheter-blocking Proteus mirabilis biofilms? : DOES DRINKING CRANBERRY JUICE PREVENT CATHETER BLOCKAGE?, 10.1046/j.1464-410x.2001.02248.x
  50. Terris Martha K, Issa Muta M, Tacker J.Ronald, Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis, 10.1016/s0090-4295(00)00884-0
  51. DE RIDDER D., van POPPEL H., DEMONTY L., D'HOOGHE B., GONSETTE R., CARTON H., BAERT L., BLADDER CANCER IN PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH CYCLOPHOSPHAMIDE, 10.1016/s0022-5347(01)63185-9
  52. Møller Jensen O., Estève J., Møller H., Renard H., Cancer in the European community and its member states, 10.1016/0277-5379(90)90278-2
  53. Kaufman Joel M., Fam Bushra, Jacobs Stephen C., Gabilondo Fernando, Yalla Subbarao, Kane James P., Rossier Alain B., Bladder Cancer and Squamous Metaplasia in Spinal Cord Injury Patients, 10.1016/s0022-5347(17)58266-x
  54. Bickel Alan, Culkin Daniel J., Wheeler John S., Bladder Cancer in Spinal Cord Injury Patients, 10.1016/s0022-5347(17)38058-8
  55. Stonehill William H., Dmochowski Roger R., Patterson Lynn A., Cox Claire E., Risk Factors for Bladder Tumors in Spinal Cord Injury Patients, 10.1016/s0022-5347(01)66232-3
Bibliographic reference De Ridder, Dirk ; Ost, D ; Van der Aa, F ; Stagnaro, M ; Beneton, C ; et. al. Conservative bladder management in advanced multiple sclerosis. In: Multiple Sclerosis : clinical and laboratory research, Vol. 11, no. 6, p. 694-699 (2005)
Permanent URL http://hdl.handle.net/2078.1/38940